ARTICLE | Clinical News
VesiculoVax-vectored Ebola virus vaccine: Phase I started
February 1, 2016 8:00 AM UTC
Profectus began a placebo-controlled, dose-escalation, U.S. Phase I trial to evaluate intramuscular VesiculoVax-vectored Ebola virus vaccine in 39 subjects. ...